<link rel="stylesheet" href="styles.f3b1fba60ec7970c.css">

How does proteomics-based prognostic testing compare to genomic tests and online clinical risk prediction tools in early breast cancer patients?

Simple item page
dc.contributor.authorBakre, M.
dc.contributor.authorDurgekar, T. S.
dc.contributor.authorShrivastava, P.
dc.contributor.authorBasaran, G.
dc.contributor.authorOzge, G.
dc.contributor.authorKorkmaz, T.
dc.date.accessioned2026-11-05T11:04:59Z
dc.date.issued2026
dc.description.volume32
dc.identifier.issn1078-0432
dc.identifier.issn1557-3265
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/11255
dc.identifier.wosWOS:001724426402381
dc.language.isoen
dc.publisherAMER ASSOC CANCER RESEARCH
dc.relation.conferenceSan Antonio Breast Cancer Symposium
dc.relation.ispartofCLINICAL CANCER RESEARCH
dc.subjectOncology
dc.titleHow does proteomics-based prognostic testing compare to genomic tests and online clinical risk prediction tools in early breast cancer patients?
dc.typeMeeting Abstract
oaire.citation.editionScience Citation Index Expanded (SCI-EXPANDED)
oaire.citation.editionConference Proceedings Citation Index - Science (CPCI-S)
oaire.citation.volume32
person.identifier.ridW-8464-2018

Files

Collections

WOS